Source: Annual Congress 2005 - The injured lung: pathogenesis and interventions
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. van den Brule, S. Godin, P. Misson, D. Lison, F. Huaux (Brussels, Belgium). Potential role of cathepsin S in bleomycin-induced lung fibrosis. Eur Respir J 2005; 26: Suppl. 49, 4642

Member's Comments

No comment yet.

Related content which might interest you: A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease? Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Cathepsins in bleomycin-induced lung injury in rat Source: Eur Respir J 2003; 22: 427-435 Year: 2003 The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Targeting of cathepsin S reduces cystic fibrosis-like lung disease Source: Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018 Year: 2019 The role of cathepsin S in lung disease Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018 Neutrophil elastase is necessary for increases in active TGF-β in bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Is cathepsin K a protective factor in the development of lung fibrosis? Source: Eur Respir J 2002; 20: Suppl. 38, 479s Year: 2002 17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 A role of Foxc2 gene in mice with bleomycin-induced pulmonary fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Cathepsin S as a mediator of acute lung inflammation Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Enhancement of bleomycin-induced lung fibrosis in tenascin C-deficient mice Source: Eur Respir J 2004; 24: Suppl. 48, 103s Year: 2004 Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation versus fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 396s Year: 2006 Effect of nintedanib on silica-induced lung inflammation and fibrosis in mice Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Time-course analysis of bleomycin-induced lung fibrosis in the rat Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Surface enolase-1 mediated cell migration and lung fibrosis in bleomycin-induced mice Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021